NOMURA HOLDINGS INC - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 182 filers reported holding NEVRO CORP in Q2 2022. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
NOMURA HOLDINGS INC ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$888,925
+145.4%
46,250
+224.6%
0.00%
+200.0%
Q2 2023$362,235
-53.4%
14,250
-33.7%
0.00%
-50.0%
Q1 2023$777,225
+88422.2%
21,500
-3.3%
0.00%
-50.0%
Q4 2022$878
-100.0%
22,229
-59.9%
0.00%
-63.6%
Q3 2022$2,597,000
-30.6%
55,414
-32.7%
0.01%
+83.3%
Q2 2022$3,740,000
+1275.0%
82,316
+2209.0%
0.01%
+500.0%
Q1 2022$272,000
-94.9%
3,565
-94.6%
0.00%
-92.9%
Q4 2021$5,370,000
+862.4%
66,211
+1549.1%
0.01%
+1300.0%
Q1 2021$558,000
-49.3%
4,015
-36.8%
0.00%
-50.0%
Q4 2020$1,100,000
+39.9%
6,351
+12.5%
0.00%0.0%
Q3 2020$786,000
+16.6%
5,6450.0%0.00%0.0%
Q2 2020$674,000
-83.5%
5,645
-86.2%
0.00%
-88.2%
Q1 2020$4,081,000
+582.4%
40,857
+704.1%
0.02%
+750.0%
Q4 2019$598,000
+101.3%
5,081
+43.1%
0.00%
+100.0%
Q3 2019$297,000
-47.7%
3,551
-74.2%
0.00%0.0%
Q2 2019$568,000
+141.7%
13,742
+263.4%
0.00%0.0%
Q1 2019$235,000
+3816.7%
3,782
+2278.6%
0.00%
Q4 2018$6,000
-98.9%
159
-97.0%
0.00%
-100.0%
Q3 2016$547,000
+41.0%
5,3000.0%0.00%
+100.0%
Q2 2016$388,0005,3000.00%
Other shareholders
NEVRO CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Tiger Eye Capital LLC 239,122$41,392,0008.25%
Integral Health Asset Management, LLC 88,000$15,233,0004.53%
Iron Triangle Partners LP 168,761$29,213,0003.79%
Eos Focused Equity Management, L.P. 14,002$2,424,0002.37%
PFM Health Sciences, LP 311,940$53,997,0001.90%
Perceptive Advisors 977,565$169,217,0001.82%
Rock Springs Capital Management LP 395,000$68,375,0001.45%
Lisanti Capital Growth, LLC 54,302$9,400,0001.30%
HealthCor Management, L.P. 156,046$27,012,0001.04%
FRED ALGER MANAGEMENT, LLC 2,136,612$369,848,0000.96%
View complete list of NEVRO CORP shareholders